NCT02115516View on ClinicalTrials.gov

Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis

PHASE1CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

April 30, 2016

Conditions
MalariaPlasmodium Falciparum Malaria
Interventions
BIOLOGICAL

PfSPZ Challenge

Aseptic, purified, vialed, cryopreserved, infectious P. falciparum sporozoites, strain NF54

BIOLOGICAL

0.9% Sodium Chloride (Placebo)

Trial Locations (1)

D-72074

Institute of Tropical Medicine, University of Tuebingen, Wilhelmstr. 27, Tübingen

All Listed Sponsors
collaborator

Institute of Tropical Medicine, University of Tuebingen

OTHER

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

lead

Sanaria Inc.

INDUSTRY

NCT02115516 - Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis | Biotech Hunter | Biotech Hunter